Aurobindo Pharma Limited announced that at its board meeting held on August 12, 2023, has accepted the resignation of Dr. M. Sivakumaran as Whole-time Director and Director of the Company, and will be relieved from his duties on close of business hours on August 24, 2023. Consequently, he shall also cease to be a member of the Corporate Social Responsibilities Committee of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,197 INR | -2.45% | -1.94% | +10.46% |
May. 27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
May. 27 | Transcript : Aurobindo Pharma Limited, Q4 2024 Earnings Call, May 27, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.46% | 8.65B | |
+42.60% | 748B | |
+32.77% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.11% | 245B | |
+9.23% | 211B | |
-3.93% | 209B | |
+1.81% | 166B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Limited Announces Resignation of M. Sivakumaran as Whole-Time Director and Director